Development of multiple-layer polymeric particles for targeted and controlled drug delivery.
The purpose of this work was to develop multilayered particles consisting of a magnetic core and two encompassing shells made up of poly(N-isopropylacrylamide) (PNIPAAm) and poly(D,L-lactide-co-glycolide) (PLGA) for targeted and controlled drug delivery. Transmission electron microscopy confirmed that multilayered particles were obtained with PNIPAAm magnetic nanoparticles embedded within the PLGA shell. Factorial analysis studies also showed that the particle size was inversely proportional to the surfactant concentration and sonication power and directly proportional to the PLGA concentration. Drug-release results demonstrated that these multilayer particles produced an initial burst release and a subsequent sustained release of both bovine serum albumin (BSA) and curcumin loaded into the core and shell of the particle, respectively. BSA release was also affected by changes in temperature. In conclusion, our results indicate that the multilayered magnetic particles could be synthesized and used for targeted and controlled delivery of multiple drugs with different release mechanisms.


BACKGROUND
Authors demonstrate the synthesis of multilayered particles consisting of a magnetic core and two encompassing shells made up of poly (N-isopropylacrylamide) (PNIPAAm) and poly(D, L-lactide-co-glycolide) (PLGA) for targeted and controlled drug delivery. The presented results indicate successful synthesis and application for targeted and controlled delivery of multiple drugs with different release mechanisms.
Koppolu
Bhanuprasanth
B
Biomedical Engineering Program, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA.
Rahimi
Maham
M
Nattama
Sivaniarvindpriya
S
Wadajkar
Aniket
A
Nguyen
Kytai Truong
KT
D000178:Acrylamides / Q000737:chemistry*; D000180:Acrylic Resins; D003692:Delayed-Action Preparations / Q000737:chemistry*; D004058:Diffusion; D016503:Drug Delivery Systems / Q000379:methods*; D019344:Lactic Acid / Q000737:chemistry*; D053758:Nanoparticles / Q000008:administration & dosage* / Q000737:chemistry*; D011100:Polyglycolic Acid / Q000737:chemistry*; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011108:Polymers / Q000737:chemistry*
D000178:Acrylamides; D000180:Acrylic Resins; D003692:Delayed-Action Preparations; D011108:Polymers; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; C052970:poly-N-isopropylacrylamide; D011100:Polyglycolic Acid; D019344:Lactic Acid
Angew Chem Int Ed Engl. 2007;46(8):1222-44
17278160
J Control Release. 2003 Jan 9;86(1):33-48
12490371
Biomaterials. 2004 May;25(10):1771-7
14738840
Biomaterials. 2005 May;26(13):1565-73
15522758
J Microencapsul. 2001 Mar-Apr;18(2):247-60
11253941
Colloids Surf B Biointerfaces. 2009 Jan 1;68(1):1-6
19013060
Adv Exp Med Biol. 2008;614:275-84
18290338
Ann Biomed Eng. 2006 Jan;34(1):23-38
16496086
Chem Asian J. 2009 Feb 2;4(2):286-93
19040251
J Colloid Interface Sci. 2001 Feb 15;234(2):356-362
11161522
J Control Release. 1999 Aug 5;60(2-3):279-86
10425333
J Nanosci Nanotechnol. 2009 Jul;9(7):4128-34
19916419
Biomaterials. 2009 Mar;30(9):1772-80
19135244
Adv Drug Deliv Rev. 2004 Sep 22;56(11):1649-59
15350294
Biotechnol Prog. 2006 Jan-Feb;22(1):118-25
16454501
Magn Reson Med. 2005 May;53(5):999-1005
15844142
J Control Release. 2001 Apr 2;71(2):203-11
11274752
Drug Discov Today. 2003 Dec 15;8(24):1112-20
14678737
Nanomedicine. 2007 Jun;3(2):132-7
17572355
Nanomedicine (Lond). 2007 Feb;2(1):23-39
17716188